AER bill signed into law
This article was originally published in The Tan Sheet
Executive Summary
President Bush signed the Dietary Supplement & Nonprescription Drug Consumer Protection Act (S 3546) into law on Dec. 26. The bill will take effect in December 2007, and FDA has until late August 2007 to provide industry with a guidance on the reporting requirements. Educating industry personnel and potential reporters of adverse events, particularly healthcare professionals, will be crucial to the success of the bill, according to industry stakeholders. "The task is now up to us to assure that the bill is understood [and that] steps are taken to implement its provisions and make sure the intent and purposes of the bill are embraced by industry," United Natural Products Association Executive Director Loren Israelsen wrote Dec. 27 (1"The Tan Sheet" Dec. 18, 2006, p. 6)...
You may also be interested in...
Experts Give AER Prep Course, Discuss Potential Potholes At UNPA Seminar
The implementation of the adverse event reporting bill will present the dietary supplement and nonprescription drug industries with challenges as well as opportunities, experts stressed at a recent United Natural Products Alliance seminar on the implementation of the new law
FDA Likely To Take Holistic View Of AER Bill Compliance, Expert Says
FDA will likely evaluate a company's compliance with adverse event reporting and record-keeping requirements on a "performance-oriented basis," said Rick Kingston, PharmD, president and senior clinical toxicologist at SafetyCall International, an adverse event call center
Adverse Event System Success Will Depend On Trained Reporters, Experts Say
Training potential reporters of adverse events may be crucial to the effectiveness of a mandatory adverse event reporting system, industry stakeholders say